GE HealthCare is buying radiopharmaceutical maker Sofie Biosciences for $945 million
The deal expands GE HealthCare's pharmaceutical diagnostics footprint and adds a late-stage cancer imaging tracer to its pipeline
The deal expands GE HealthCare's pharmaceutical diagnostics footprint and adds a late-stage cancer imaging tracer to its pipeline